Valiltramiprosate

Valiltramiprosate
Clinical data
Other names	ALZ-801; BLU8499
Legal status
Legal status	Investigational;
Identifiers
	IUPAC name 3-[[(2S)-2-amino-3-methylbutanoyl]amino]propane-1-sulfonic acid;
CAS Number	1034190-08-3;
PubChem CID	25008296;
DrugBank	DB19191;
ChemSpider	27819042;
UNII	GHG2B47067;
KEGG	D12218;
ChEMBL	ChEMBL4650301;
Chemical and physical data
Formula	C8H18N2O4S
Molar mass	238.30 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC(C)[C@@H](C(=O)NCCCS(=O)(=O)O)N;
	InChI InChI=1S/C8H18N2O4S/c1-6(2)7(9)8(11)10-4-3-5-15(12,13)14/h6-7H,3-5,9H2,1-2H3,(H,10,11)(H,12,13,14)/t7-/m0/s1; Key:NRZRFNYKMSAZBI-ZETCQYMHSA-N;

Valiltramiprosate is an investigational new drug that is being evaluated to treat early Alzheimer's disease.^[1] It is an amyloid precursor protein antagonist.^[2]

References

^ "Valiltramiprosate - Alzheon". AdisInsight. Springer Nature Switzerland AG.
^ Lee D, Antonsdottir IM, Clark ED, Porsteinsson AP (May 2024). "Review of valiltramiprosate (ALZ-801) for the treatment of Alzheimer's disease: a novel small molecule with disease modifying potential". Expert Opinion on Pharmacotherapy. 25 (7): 791–799. doi:10.1080/14656566.2024.2360069. PMID 38814590.

This pharmacology-related article is a stub. You can help Wikipedia by expanding it.